Document is current
Any future updates will be listed below
-
Authors
Hossein, Amin http://orcid.org/0000-0002-5122-9927
Rabineau, Jérémy
Gorlier, Damien
Pinki, Farhana
van de Borne, Philippe
Nonclercq, Antoine
Migeotte, Pierre-François
-
Funding
Funding for this research was provided by:
Fonds pour la Formation à la Recherche dans l’Industrie et dans l’Agriculture (FC 29801)
Belgian Federal Science Policy Office (PRODEX PEA 4000110826, PRODEX PEA 4000110826, PRODEX PEA 4000110826)
- License Information
-
More Information
Article History
Received: 17 September 2020
Accepted: 10 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: The study protocol complied with the Declaration of Helsinki, was approved by the local Ethics Committee (Hôpital Erasme—CCB: B406201630013), and was registered on ClinicalTrials.org (April 11, 2017), identifier NCT03107351. The prototype of the KCG device used in this clinical trial was authorised by the Belgian Federal Agency for Medicine and Health Products (FAMHP). Written informed consent was obtained from each participant prior to the experimental testing procedure.
: Not applicable.
: A.H, P.F.M., D.G.: HeartKinetics minority shareholder. The other authors declare no conflict of interest.
